Oxazepam

CHEMBL568 Phase 4 Approuvé Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

286.7 g/mol

LogP

2.2

Phase

4

A moderate-acting benzodiazepine for anxiety and alcohol withdrawal, less likely to accumulate in elderly patients.

Masse moléculaire

286,7100 g/mol

LogP

2,20

TPSA

61,70 Å²

Règle des 5 de Lipinski

Conforme

Aires thérapeutiques

Schizophrenia Generalized Anxiety Disorder

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Structure 2D

SVG PNG

Cite this structure

Embed this structure

SMILES

O=C1Nc2ccc(Cl)cc2C(c2ccccc2)=NC1O

InChI

InChI=1S/C15H11ClN2O2/c16-10-6-7-12-11(8-10)13(9-4-2-1-3-5-9)18-15(20)14(19)17-12/h1-8,15,20H,(H,17,19)

Molecular Formula

C15H11ClN2O2

HBD / HBA

2 / 3

Liaisons Rotatives

1

Atomes Lourds

20

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Foire aux questions

A moderate-acting benzodiazepine for anxiety and alcohol withdrawal, less likely to accumulate in elderly patients.

Yes, Oxazepam is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL568. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 4616. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

PillFYI

Vous cherchez des informations accessibles aux patients ?

Oxazepam sur PillFYI

Structure

Données Clés

Formule: C15H11ClN2O2

Liens externes

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Avertissement médical

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.